GALT Competitors
Galectin Therapeutics Inc.
$3.94
+$0.30(+8.24%)
35
Overall
40
Value
40
Tech
26
Quality
Market Cap
$398.13M
Volume
156.41K
52W Range
$2.03 - $7.13
Target Price
$11.00
GALT competitors: MEIP, NBIX, NAVB, NBY. Galectin Therapeutics Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
GALT Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| NBIX Neurocrine Biosciences, Inc. | $142.44 | $14.48B | $7.26 | - | 53 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GALT | $3.94 | +8.2% | 156.41K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Galectin Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW